Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$0.07.

  • Integra Lifesciences Holdings' EPS (Basic) rose 5000.0% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.46, marking a year-over-year decrease of 797500.0%. This contributed to the annual value of -$0.09 for FY2024, which is 11060.82% down from last year.
  • Integra Lifesciences Holdings' EPS (Basic) amounted to -$0.07 in Q3 2025, which was up 5000.0% from -$6.31 recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' EPS (Basic) registered a high of $0.64 during Q4 2022, and its lowest value of -$6.31 during Q2 2025.
  • Moreover, its 5-year median value for EPS (Basic) was $0.26 (2023), whereas its average is -$0.09.
  • Per our database at Business Quant, Integra Lifesciences Holdings' EPS (Basic) soared by 963359.78% in 2021 and then crashed by 384375.0% in 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' EPS (Basic) (Quarter) stood at $0.54 in 2021, then rose by 18.52% to $0.64 in 2022, then tumbled by 59.38% to $0.26 in 2023, then decreased by 2.93% to $0.25 in 2024, then tumbled by 127.74% to -$0.07 in 2025.
  • Its EPS (Basic) stands at -$0.07 for Q3 2025, versus -$6.31 for Q2 2025 and -$0.33 for Q1 2025.